Displaying 1..1 of 1 -
per page
Order by
TAPESTRY PHARMACEUTICALS ANNOUNCES PLAN TO DISCONTINUE GENE EDITING OPERATIONS-Company to Focus on Lead Oncology Compounds-
More
Displaying 1..1 of 1 -
per page
Order by
Feb 2011 - 100 pages - $500
Oct 2009 - 17 pages - $500
Feb 2011 - 134 pages - $500
Nov 2010 - 481 pages - $1,495
Nov 2010 - 40 pages - $500
Nov 2010 - 45 pages - $2,000
Oct 2011 - 134 pages - $500
Aug 2011 - 6 pages - $500
Mar 2011 - 34 pages - $1,000